Balanced portfolio – SELL Corporate Travel Management Limited (CTD)
Sell Corporate Travel Management CTD:ASX
Balanced Portfolio
Earnings Update – Corporate Travel Management Limited (CTD)
Corporate Travel Management Limited (CTM) has reported mixed financial results for the first half of 2025 (1H25), demonstrating both growth and challenges across its operating segments. The company has emphasized strong capital management, operational efficiency improvements through automation and AI, and strategic transitions in service provision. Notably, CTM has secured the sole provider status for the UK Government’s Travel Management Consultant (TMC) travel services framework, marking a significant shift from a competitive trio to a singular supplier role. This strategic move is expected to bolster long-term revenue streams and market presence in the Rest of World (RoW) regions.
Balanced Portfolio – Sell Challenger (CGF)
Following the earnings release, the stock experienced a sharp 7% sell-off at market open. This pronounced negative reaction indicates that investors are increasingly wary of the sustainability of the reported earnings growth amid evident headwinds.
Earnings Update – BHP Group Limited (BHP)
Challenger exceeded EPS expectations and maintained strong capital and cost control, but asset and liability experience losses, weaker annuity sales, and accounting distortions impacted statutory profits. While structural improvements in capital efficiency and expense management are evident, sales momentum in annuities remains a key challenge going into H2 FY25.
Earnings Update – Challenger Ltd (CGF)
Challenger exceeded EPS expectations and maintained strong capital and cost control, but asset and liability experience losses, weaker annuity sales, and accounting distortions impacted statutory profits. While structural improvements in capital efficiency and expense management are evident, sales momentum in annuities remains a key challenge going into H2 FY25.
Earnings Update – Sell Audinate Group Ltd (AD8)
Audinate Group Limited reported 1H25 earnings that exceeded market expectations, particularly in terms of EPS (-$0.02 vs. -$0.12 expected). However, the company remains in a transitional phase, dealing with ongoing inventory overhang from OEM customers while seeing promising growth in software revenues and product mix shifts.
Balanced/income – ADD CSL Limited CSL:ASX
Balanced/income – ADD CSL Limited CSL:ASX
Growth Watchlist update – Macquarie Group MQG:ASX
Earnings update for Macquarie group MQG:ASX
US Stocks Watchlist – Palantir PLTR:NASDAQ Update
Palantir Technologies jumped 22% after reported upbeat guidance and better than expected fourth-quarter results
A.I. 2.0 – Where to Invest in the Second Wave of AI
Kai Chen and Mark Gardner talk about the next phase of AI investment
Growth Watchlist update – Telix Pharma TLX:ASX
Business update for Telix pharma TLX:ASX